Recently, it has been reported that in multiple myeloma and hepatocellular carcinoma, CD155 expression is induced by IL-8, activating NF-κB signaling, and IL-22 activates STAT3, respectively [22,23]. The gene discussed is IL22; the disease is plasma cell myeloma.